{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:36:10Z","timestamp":1740461770782,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI155536","75N93022C00036"],"award-info":[{"award-number":["R01AI155536","75N93022C00036"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmcl.2025.130092","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:24:24Z","timestamp":1736209464000},"page":"130092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure guided modification of 2-chloro-5-(ethyl-phenyl-sulfamoyl)-N-[2-(2-oxo-pyrrolidin-1-yl)-phenyl]-benzamide to afford selective inhibitors of Cryptosporidium parvum N-myristoyltransferase"],"prefix":"10.1016","volume":"119","author":[{"given":"Dilep K.","family":"Sigalapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Groustra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Zigweid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Hulverson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Owsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Khim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley C.","family":"Van Voorhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart L.","family":"Staker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130092_b0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.emboj.7600093","article-title":"Crystal structure of a myristoylated CAP-23\/NAP-22 N-terminal domain complexed with Ca2+\/calmodulin","volume":"23","author":"Matsubara","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.bmcl.2025.130092_b0010","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.87.2.728","article-title":"G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells","volume":"87","author":"Mumby","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2025.130092_b0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.3917576","article-title":"Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein","volume":"227","author":"Schultz","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2025.130092_b0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw4912","article-title":"A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation","volume":"365","author":"Timms","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2025.130092_b0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0960-894X(01)00319-5","article-title":"Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 1","volume":"11","author":"Masubuchi","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130092_b0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1074-5521(02)00240-5","article-title":"Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors","volume":"9","author":"Sogabe","year":"2002","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130092_b0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/cb5008647","article-title":"N-myristoyltransferase is a cell wall target in Aspergillus fumigatus","volume":"10","author":"Fang","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130092_b0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1107\/S1399004715000401","article-title":"Structure of N-myristoyltransferase from Aspergillus fumigatus","volume":"71","author":"Shimada","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bmcl.2025.130092_b0045","article-title":"Discovery of novel myristic acid derivatives as N-myristoyltransferase inhibitors: design, synthesis, analysis, computational studies and antifungal activity","volume":"12","author":"Javid","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bmcl.2025.130092_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41119-7","article-title":"Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts","volume":"14","author":"Rodriguez-Hernandez","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130092_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2019.03.015","article-title":"Structure-guided identification of resistance breaking antimalarial N\u2011myristoyltransferase inhibitors","volume":"26","author":"Schlott","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130092_b0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchem.1830","article-title":"Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach","volume":"6","author":"Wright","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0065","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1021\/jm301160h","article-title":"Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery","volume":"55","author":"Yu","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0070","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1074\/jbc.M211391200","article-title":"Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites","volume":"278","author":"Price","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20131033","article-title":"Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase","volume":"459","author":"Roberts","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2025.130092_b0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130092_b0085","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1021\/acs.jmedchem.4c00168","article-title":"Exploring subsite selectivity within Plasmodium vivax N-myristoyltransferase using pyrazole-derived inhibitors","volume":"67","author":"Rodriguez-Hernandez","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0090","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2025.130092_b0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2025.130092_b0100","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/acsinfecdis.3c00151","article-title":"Identification of and structural insights into hit compounds targeting N-myristoyltransferase for Cryptosporidium drug development","volume":"9","author":"Fenwick","year":"2023","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130092_b0105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/acs.jmedchem.9b01343","article-title":"Identification of selective inhibitors of Plasmodium N-myristoyltransferase by high-throughput screening","volume":"63","author":"Harupa","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1107\/S2052252514013001","article-title":"Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors","volume":"1","author":"Brannigan","year":"2014","journal-title":"IUCrJ"},{"key":"10.1016\/j.bmcl.2025.130092_b0115","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1021\/jm5011397","article-title":"Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors","volume":"57","author":"Hutton","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0120","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1021\/acs.jmedchem.9b00586","article-title":"How to design selective ligands for highly conserved binding sites: a case study using N-myristoyltransferases as a model system","volume":"63","author":"Kersten","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0125","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1039\/C5MD00242G","article-title":"Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase","volume":"6","author":"Yu","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2025.130092_b0130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/jm201091t","article-title":"Discovery of a novel class of orally active Trypanocidal N-myristoyltransferase inhibitors","volume":"55","author":"Brand","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ab.2011.10.013","article-title":"A fluorescence-based assay for N-myristoyltransferase activity","volume":"421","author":"Goncalves","year":"2012","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2025.130092_b0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/187152609789105687","article-title":"The Seattle Structural Genomics Center for Infectious Disease (SSGCID)","volume":"9","author":"Myler","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.bmcl.2025.130092_b0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41586-020-2131-1","article-title":"Discovery and characterization of an acridine radical photoreductant","volume":"580","author":"MacKenzie","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130092_b0155","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/acs.orglett.3c00193","article-title":"Hydride transfer-initiated cross-dehydrogenative coupling reaction to access nine-membered rings","volume":"25","author":"An","year":"2023","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2025.130092_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103188","article-title":"Discovery of certain benzyl\/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study","volume":"92","author":"Sigalapalli","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130092_b0165","doi-asserted-by":"crossref","first-page":"34468","DOI":"10.1039\/C5RA24527C","article-title":"One-pot synthesis of amides from carboxylic acids activated using thionyl chloride","volume":"6","author":"Leggio","year":"2016","journal-title":"RSC Adv"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:38:24Z","timestamp":1740454704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"alternative-id":["S0960894X25000010"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130092","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure guided modification of 2-chloro-5-(ethyl-phenyl-sulfamoyl)-N-[2-(2-oxo-pyrrolidin-1-yl)-phenyl]-benzamide to afford selective inhibitors of Cryptosporidium parvum N-myristoyltransferase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130092"}}